Meta-analysis of long-term outcomes of percutaneous coronary intervention versus medical therapy in stable coronary artery disease

Eur J Prev Cardiol. 2019 Mar;26(4):433-436. doi: 10.1177/2047487318800511. Epub 2018 Sep 18.

Authors

Safi U Khan¹, Maninder Singh², Ahmad N Lone¹, Muhammad Shahzeb Khan³, Urooj Fatima⁴, Abu Bakar Saad⁵, Haris Riaz⁶, Isaac Opoku-Asare⁴, Edo Kaluski²

Affiliations

¹ 1 Department of Medicine, West Virginia University, USA.
² 2 Department of Cardiovascular Medicine, Guthrie Health System/Robert Packer Hospital, USA.
³ 3 Department of Medicine, Cook County Hospital, USA.
⁴ 4 Department of Cardiovascular Medicine, Howard University Hospital, USA.
⁵ 5 Department of Cardiovascular Medicine, Nishtar Hospital, Pakistan.
⁶ 6 Department of Cardiovascular Medicine, Cleveland Clinic, USA.

No abstract available

Publication types

Letter
Meta-Analysis
Review

MeSH terms

Cardiovascular Agents / adverse effects
Cardiovascular Agents / therapeutic use*
Coronary Artery Disease / diagnosis
Coronary Artery Disease / mortality
Coronary Artery Disease / therapy*
Female
Humans
Male
Middle Aged
Percutaneous Coronary Intervention* / adverse effects
Percutaneous Coronary Intervention* / mortality
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome

Substances

Cardiovascular Agents

Grants and funding

U54 GM104942/GM/NIGMS NIH HHS/United States